Background-Heart rate variability is thought to measure autonomic modulation, but the relation has never been demonstrated directly in humans. Aim-To test the hypothesis that increased low frequency heart rate variability reflects sympathetic reinnervation after cardiac transplantation. Patients-24 cardiac transplant recipients at the time of routine surveillance coronary angiography two or more years after cardiac transplantation, and 10 controls with normal coronary arteries undergoing angiography for investigation of chest pain. Setting-Regional cardiothoracic centre. Methods-Sympathetic effector function at the sinus node was assessed by measuring the fall in cycle length for two minutes after injection of tyramine to the artery supplying the sinus node. Heart rate variability was measured from three-minute RR interval sequences at rest, during metronomic respiration, and before and after atropine. Results-The logarithm of the low frequency component of heart rate variability during metronomic respiration was linearly related to the logarithm of the change in cycle length after injection of tyramine (R2 = 0-28, P = 0.007). Absolute units more accurately reflected sympathetic effector function than did normalised units or the ratio of low frequency to high frequency. Atropine did not affect high frequency heart rate variability in transplant recipients. Conclusions-The low frequency component of heart rate variability is directly related to sympathetic reinnervation to the sinus node. (Heart 1997;77:532-538) Keywords: heart rate variability; reinnervation; sympathetic nervous system; cardiac transplantation Heart rate variability is mediated by cardiac nerves, and has been used as a measure of "autonomic tone". The precise relation between heart rate variability and autonomic innervation has not been measured directly, but has been inferred from the fact that heart rate variability is reduced immediately after transplantation when all extracardiac nerves to the sinus node are divided, and because it may be abolished using pharmacological autonomic blockade.l-4
Heart rate variability is mediated by cardiac nerves, and has been used as a measure of "autonomic tone". The precise relation between heart rate variability and autonomic innervation has not been measured directly, but has been inferred from the fact that heart rate variability is reduced immediately after transplantation when all extracardiac nerves to the sinus node are divided, and because it may be abolished using pharmacological autonomic blockade.l- 4 The spectrum obtained from frequency analysis of sequences of RR intervals may be divided into two parts, a low frequency (LF) component and a high frequency (HF) component. The LF component is thought to be related to both sympathetic and parasympathetic innervation, and the HF component to parasympathetic innervation alone on the basis of experiments involving specific intravenous autonomic blocking agents. '-3 Heart rate variability increases with time after transplantation, suggesting that reinnervation occurs.56 We7 and others89 have observed sympathetic reinnervation after cardiac transplantation using intracoronary injection of tyramine, which causes release of noradrenaline only from intact presynaptic sympathetic nerve terminals, and so causes a change in heart rate only if reinnervation has taken place. In contrast to previous demonstrations of sympathetic reinnervation we'0 and others41I have not been able to demonstrate parasympathetic reinnervation. Assuming that parasympathetic reinnervation does not occur, and that we can quantitate sympathetic reinnervation using tyramine, the cardiac transplant recipient is therefore a new model of denervation and partial sympathetic reinnervation with which to investigate the specific contribution of cardiac nerves to autonomic function.
The aim of this study was to examine the relation between sympathetic and parasympathetic innervation of the heart, and the various components of heart rate variability using the cardiac transplant recipient as a model. We hypothesised that LF but not HF measures of heart rate variability would be related to response to tyramine among transplant recipients, and that atropine would have no effect on heart rate variability in transplant recipients.
Methods

SUBJECTS
Twenty four cardiac transplant recipients were studied at the time of routine surveillance coronary angiography two or more years after transplantation. All were in sinus rhythm and none had overt sinus node dysfunction. Donor and recipient age and time after transplantation were recorded. Calcium channel blocking agents and nitrates were discontinued at least 36 hours before all studies. None was taking ,B blockers. Immunosuppression including cyclosporin, azathioprine, and prednisolone was continued throughout. Subjects with permanent pacemakers, diabetes or significant renal impairment were excluded.
Ten control subjects were recruited from a population awaiting coronary angiography for assessment of chest pain. Subjects were selected prospectively if they had a low prior probability of coronary artery disease on clinical grounds. ,B blockade, calcium channel blockade, and nitrates were discontinued at least 36 hours before the angiogram and before all studies. Potential control subjects were excluded at the time of angiography if there was any impairment of ventricular function, any valve lesions or any significant coronary artery lesions (stenosis > 50%).
Approval was obtained from the Joint Ethical Committee of the University of Newcastle upon Tyne and Newcastle Health Authority, and prior informed consent was obtained from all subjects.
INTRACORONARY TYRAMINE
After routine coronary angiography, either for surveillance (transplant recipients) or investigation of chest pain (control subjects), tyramine was injected into each coronary artery following the protocol of Wilson et al.8 Tyramine (8 jg/kg) was injected into the left coronary artery and then (4 jg/kg) into the right; the catheter was immediately flushed with heparinised saline after each injection. Surface ECGs were recorded from a chest lead at a paper speed of 100 mm/s for 10 beats before and at least two minutes after tyramine injection. Coronary angiograms were then reviewed to identify the sinus node artery, and consecutive RR intervals were measured manually in milliseconds from the record of that injection using a digitising tablet (Calcomp 2000, Anaheim, California, USA) linked to a personal computer via the serial port.
Resting cycle length was averaged over 10 beats before injection. The minimum cycle length averaged over three consecutive sinus beats was determined from the RR interval series, and was confirmed by inspection of the ECG and the tachogram. Responses to tyramine were calculated as the natural logarithm of the difference between the resting and minimum cycle lengths, and expressed as changes in heart rate after injection of tyramine to allow comparison with Wilson's original data.
HEART RATE VARIABILITY Transplant recipients were studied supine six hours after angiography. Control subjects were studied supine six hours after angiography and again at between six and 17 months following angiography. Two three-minute ECG recordings were made from a chest lead. During the second recording, the subject was instructed to breathe in time with a signal from the investigator at a rate of 10 breaths per minute (0-167 Hz). All RR intervals from each recording were then measured manually in milliseconds using a digitising tablet as above. Any ectopic beats were identified and the short coupling interval and compensatory pause replaced by an interval length equal to the mean of the two preceding RR intervals. No recording had more than seven ectopic beats. After preliminary analysis of the results, it was decided to assess the contribution of parasympathetic innervation to heart rate variability. Heart rate variability was assessed after parasympathetic blockade in the 10 control subjects who were restudied both before and after atropine, and the final nine transplant recipients. Three-minute RR interval traces were recorded at rest and during metronomic respiration both before and after intravenous injection of 1 8 mg atropine.
STATISTICAL ANALYSIS
The distribution of the heart rate variability data was found to be skewed, therefore, all values were logarithmically transformed to approximate a normal distribution. Similarly, response to tyramine was expressed as the logarithm of the absolute change in cycle length after intracoronary injection. Values were compared between groups using Student's t test, and between resting and metronomic respiration, and before and after atropine in the same subjects using paired t testing. Relations between response to tyramine and heart rate variability were analysed using linear regression. Significance was set at P < 0.05.
Results
SUBJECTS
Donor and recipient age, and time after transplantation are presented in table 1.
RESPONSE TO INTRACORONARY TYRAMINE
Heart rate increased after intracoronary tyramine by a median of 18 (range 1 to 63) beats per minute in transplant recipients, and by a median of 30 (range 15 to 67) beats per minute in controls. Heart rate rose by more than five beats per minute in 21 of 24 cardiac transplant recipients and in all control subjects, meeting Wilson's definition of reinnervation. 8 Example patterns of response to tyramine are shown in figure 1 for a control subject, a transplant recipient with no evidence of reinnervation, and a transplant recipient with evidence of reinnervation.
HEART RATE VARIABILITY Figure 1 also shows examples of spectra derived from the resting RR interval sequences in the same subjects. Although there is a dramatic response to tyramine in the transplant recipient with evidence of reinnervation, this is reflected only in an attenuated LF peak, and the continuing absence of an HF peak. of the measurements of heart rate variability was assessed by comparing the difference of each pair of values to its mean. For LF content of the spectrum the mean difference was -0 39 units (range -1 63 to 1 87) and for HF content of the spectrum the mean difference was -033 units (range -212 to 1-33).
RELATION OF HEART RATE VARIABILITY TO RESPONSE TO TYRAMINE Low frequency Among transplant recipients there was a significant relation between the LF component of the 7 spectrum and response to tyramine only during metronomic respiration (R2 = 0-28, P = 0 007) (fig 2) .
High frequency
The relation between HF content and response to tyramine was not significant in transplant recipients, unlike that between LF content and response to tyramine (fig 3) . 
Discussion
This study has shown that heart rate variability is directly related to sympathetic reinnervation to the sinus node, confirming the inference of Bemardi and colleagues,'4 and the assumptions of others.5615 It has also suggested that sympathetic effector function contributes to HF variation, previously thought to be related 7 to parasympathetic innervation alone.
HEART RATE VARIABILITY IN NORMAL
SUBJECTS
Variations in heart rate are thought to be caused by cardiac nerves because pharmacological and surgical autonomic blockade abolish them.'4 These variations may be analysed in more detail using frequency analysis to extract the proportion of the variability in the signal that can be explained by oscillations at each of the measured frequencies. A number of investigators has shown that typical spectra obtained from normal subjects contain peaks in an LF and an HF region.' 2 The HF peak has been related to parasympathetic nerves because it is 7 abolished by atropine. The LF peak is affected by both atropine and sympathetic blockade, and its relation to the HF peak is possibly related to the sensitivity of the mechanism by which changes in blood pressure affect heart Response to tyramine relation between time after transplantation and the increase in LF power. This increase was blocked in four subjects after injection of esmolol suggesting sympathetic reinnervation. However, other factors may also play a part. Their method, using neck suction, involves the baroreceptors, and baroreflex sensitivity is reduced in subjects with heart failure.'8 Cardiac transplant recipients are survivors of cardiac failure, and although the reduced baroreflex sensitivity may recover with time, it does not do so completely. '9 Other groups have also demonstrated increases in LF power but have not related these to direct measures of reinnervation.56 '5 We have shown that the LF part of the spectrum relates to a more direct measure of the degree of reinnervation, albeit a somewhat weak relation over the population as a whole. Response to tyramine Figure 4 Relation between response to tyramine and the low frequency (LF) content of the spectrum in control subjects recorded at rest (upper panel) and during metronomic respiration (lower panel). Data from transplant recipients after atropine are not presented Data from control subjects before atropine are shown as diamonds, andfrom control subjects after atropine as closed squares. Relations from the first experiment are reproducec as dashed lines for comparison. *Correlations statistically significant (P < 0 05). rate, the baroreflex.'6 Both heart rate variabilii and baroreflex sensitivity show wide variation i a normal population both within and betwee subjects.'7 We have analysed very short sel ments of data to minimise the contribution influences affecting heart rate variability, suc as concentrations of hormones that act ov longer time periods. We used metronomic re piration to standardise the response, and used relatively low frequency (0 167 Hz) because M observed that higher frequencies caused signif cant changes in resting heart rate during ti procedure, possibly related to falling arteri carbon dioxide tension.
HEART RATE VARIABILITY AFTER CARDIAC TRANSPLANTATION Heart rate variability is not determined only t the integrity of cardiac efferent nerves but als by the sensitivity and gain of central reflexe and the integrity and responsiveness of afferei cardiac and sino-aortic sensory nerves. Only very small proportion of variability persis immediately after transplantation and can t ascribed to the direct effects of stretch on ti sinus node, or to persistent intracardiac gat glia. 4 9 have already demonstrated that intracoronary injection of tyramine causes an increase in heart rate of more than five beats per minute in up to two ty thirds of subjects long term after cardiac transin plantation. Heart rate changes have been n related to noradrenaline spillover during susg-tained handgrip, suggesting that the change in of heart rate may be used to estimate the amount of -h noradrenaline released, although this does not er take into account differences in receptor sensis-tivity. 25 The fact that response to tyramine a relates to peak heart rate response during exerve cise in cardiac transplant recipients7 suggests fi-that the response to tyramine is a measure of ie the capacity of cardiac nerves to influence heart al rate.
A number of approaches have been used to detect potential parasympathetic reinnervation.9 10 Response to tyramine HEART RATE VARIABILITY AND RESPONSE TO TYRAMINE IN CONTROL SUBJECTS Our control population cannot be assumed to have normal cardiac innervation and indeed showed evidence of a range of responsiveness to tyramine consistent either with partial cardiac denervation or reduced receptor sensitivity in some subjects. The difference in total spectral content between control subjects and transplant recipients may be explained either by normal parasympathetic innervation or by much increased sino-aortic baroreflex sensitivity in the control subjects. We studied a small number of control subjects, and found variation in all measurements of heart rate variability to be high, consistent with the observations of others.'7 Response to tyramine Figure 5 Relation between response to tyramine and the high frequency (HF) content Values are expressed as mean (SD). *Significant differences before and after atropine, P < 0-001. Difference between transplant recipients and controls and between subjects at rest and during metronomic respiration are not shown.
LIMITATIONS
Recommendations for standards of measurement of heart rate variability have recently been published. 17 As we designed and performed our study before their publication, we were unable to use them. However, the methods used in our study do not differ very much from those recommended. Heart rate variability after atropine was measured in control subjects both at the time of angiography and at a variable interval later, -while transplant recipients were studied only on the day of their angiogram. As discussed earlier, the poor reproducibility of measures of 7f heart rate variability means that the relations between response to tyramine and heart rate variability among controls must be interpreted d with caution. Because the experiments were performed at the time of angiography, and intracoronary injection of tyramine depletes presynaptic stores of noradrenaline for some time, we were unable to assess the reprotic ducibility of the response to tyramine. le,
The respiratory frequency we chose was reln-atively close to the (arbitrary) division between )re the LF and HF bands, and thus some of the 'ee variation caused by respiration may have la-leaked into the LF band. In order to exclude a ise significant contribution from this effect we is-reanalysed the metronomic respiration data in using a single long sequence of RR intervals via allowing accurate localisation of the HF peak, :or albeit with increased variance. As we had lar hypothesised the relations between LF power and response to tyramine remained the same despite reduced leakage of the HF peak into the LF region, suggesting that its contribution is not important.
CONCLUSIONS
This is the first direct demonstration that increased heart rate variability is related to cardiac sympathetic reinnervation after cardiac transplantation. We 
